Detalles de la búsqueda
1.
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Cancer Immunol Immunother
; 65(1): 25-36, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581199
2.
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.
Cancer Immunol Immunother
; 63(8): 779-86, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24756419
3.
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence.
Cancer Immunol Immunother
; 62(8): 1327-34, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23666534
4.
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100309
5.
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
J Immunother Cancer
; 9(5)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34035112
6.
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
J Immunother Cancer
; 9(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479025
7.
Malignant gastrointestinal neuroectodermal tumour of the oesophagus with pulmonary metastasis and protracted survival.
Histopathology
; 67(6): 927-30, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018740
8.
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.
J Cutan Pathol
; 37(1): 94-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19602071
9.
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
J Immunother Cancer
; 7(1): 163, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248461
10.
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines.
Ann Surg Oncol
; 15(12): 3538-49, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18923873
11.
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Adv Immunol
; 90: 243-95, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16730266
12.
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Clin Cancer Res
; 13(21): 6386-95, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17975151
13.
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
J Clin Oncol
; 22(22): 4474-85, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15542798
14.
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
J Clin Oncol
; 21(21): 4016-26, 2003 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581425
15.
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes.
J Immunother Cancer
; 2: 23, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126421
16.
Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy.
J Clin Oncol
; 36(26): 2743-2744, 2018 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020819
17.
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Clin Cancer Res
; 19(13): 3611-20, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23620404
18.
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
J Clin Oncol
; 29(21): 2924-32, 2011 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21690475
19.
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
Clin Cancer Res
; 17(23): 7440-50, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976537
20.
Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
Clin Colorectal Cancer
; 14(1): e1-3, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25600448